Table 1 Patient demographics and clinical data according to Definition I
SMuRFs-present ACS (n = 5296) | SMuRFs-absent ACS (n = 392) | P-value | |
|---|---|---|---|
Age, years | 59.68 ± 10.81 | 61.90 ± 11.07 | < 0.001 |
Male | 4064 (76.74%) | 235 (59.95%) | < 0.001 |
BMI, kg/m2 | 24.61 ± 2.94 | 23.37 ± 3.13 | < 0.001 |
Family history of CAD | 612 (11.56%) | 20 (5.10%) | < 0.001 |
Anemia | 510 (9.79%) | 48 (12.34%) | 0.105 |
Type of CAD | - | - | 0.022 |
STEMI | 1910 (36.06%) | 167 (42.60%) | - |
NSTEMI | 664(12.54%) | 38(9.69%) | - |
UA | 2722 (51.40%) | 187 (47.70%) | - |
Smoking | - | - | < 0.001 |
None | 2298 (43.39%) | 392 (100.00%) | - |
Current | 2576 (48.64%) | 0 (0.00%) | - |
Former | 422 (7.97%) | 0 (0.00%) | - |
eGFR, mL/min/1.73m2 | 112.91 ± 40.25 | 111.57 ± 35.42 | 0.477 |
TC, mmol/L | 4.46 ± 1.21 | 4.49 ± 0.86 | 0.538 |
LDL-C, mmol/L | 2.61 ± 1.04 | 2.60 ± 0.77 | 0.838 |
HDL-C, mmol/L | 1.05 ± 0.34 | 1.30 ± 0.30 | < 0.001 |
LVEF, % | 60.31 ± 8.72 | 60.06 ± 8.49 | 0.582 |
Medical therapy at discharge | |||
Aspirin | 5228 (98.72%) | 385 (98.21%) | 0.401 |
Clopidogrel | 5208 (98.34%) | 383 (97.70%) | 0.349 |
β-blocker | 4048 (76.44%) | 281 (71.68%) | 0.033 |
ACEI/ARB | 3773 (71.24%) | 211 (53.83%) | < 0.001 |
Statin | 5116 (96.60%) | 388 (98.98%) | 0.010 |
PPI | 2039 (38.50%) | 139 (35.46%) | 0.232 |